Correction : Reduced CD160 Expression Contributes to Impaired NK-cell Function and Poor Clinical Outcomes in Patients with HCC
| Errataetall: |
ErratumFor: Cancer Res. 2018 Dec 1;78(23):6581-6593. - PMID 30232222 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:79 |
|---|---|
| Enthalten in: |
Cancer research - 79(2019), 7 vom: 01. Apr., Seite 1714 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sun, Haoyu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 20.11.2019 published: Print ErratumFor: Cancer Res. 2018 Dec 1;78(23):6581-6593. - PMID 30232222 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1158/0008-5472.CAN-19-0630 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM295580682 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM295580682 | ||
| 003 | DE-627 | ||
| 005 | 20231225083955.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1158/0008-5472.CAN-19-0630 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0985.xml |
| 035 | |a (DE-627)NLM295580682 | ||
| 035 | |a (NLM)30936078 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sun, Haoyu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction |b Reduced CD160 Expression Contributes to Impaired NK-cell Function and Poor Clinical Outcomes in Patients with HCC |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.11.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumFor: Cancer Res. 2018 Dec 1;78(23):6581-6593. - PMID 30232222 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Xu, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Qiang |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Mei |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Kun |e verfasserin |4 aut | |
| 700 | 1 | |a Qu, Kun |e verfasserin |4 aut | |
| 700 | 1 | |a Wen, Hao |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Renyong |e verfasserin |4 aut | |
| 700 | 1 | |a Zheng, Meijuan |e verfasserin |4 aut | |
| 700 | 1 | |a Wei, Haiming |e verfasserin |4 aut | |
| 700 | 1 | |a Xiao, Weihua |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Rui |e verfasserin |4 aut | |
| 700 | 1 | |a Tian, Zhigang |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Cheng |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer research |d 1945 |g 79(2019), 7 vom: 01. Apr., Seite 1714 |w (DE-627)NLM000001740 |x 1538-7445 |7 nnns |
| 773 | 1 | 8 | |g volume:79 |g year:2019 |g number:7 |g day:01 |g month:04 |g pages:1714 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1158/0008-5472.CAN-19-0630 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 79 |j 2019 |e 7 |b 01 |c 04 |h 1714 | ||